June 7 | 2022 2cureX AB announces share purchase by the company’s Chairman of the Board of Directors and Executive Management Read more
May 20 | 2022 We invite you to join the 2cureX Q1 Report webcast and Q&A session at 15:00 on 24 May, 2022 Read more
May 9 | 2022 2cureX presents IndiTreat® clinical results at the Society for Functional Precision Medicine Read more
May 6 | 2022 2cureX utser Sedermera Corporate Finance AB till likviditetsgarant för bolagets aktie Read more
May 6 | 2022 2cureX appoints Sedermera Corporate Finance AB to act as a liquidity provider for the Company´s share Read more